Trial results for a study investigating interventions to increase biomedical HIV prevention uptake were posted on ClinicalTrials.gov on 2026-03-11, showing uptake rates of approximately 24% in both intervention and control groups.
Background
HIV/AIDS remains a significant global health challenge, particularly in regions like East Africa. Biomedical HIV prevention options, such as pre-exposure prophylaxis (PrEP), are highly effective tools in reducing new HIV infections. However, their public health impact depends on consistent uptake and adherence. Innovative strategies are needed to reach populations who may face barriers to accessing these services, including those who frequent social venues like drinking establishments, to ensure broader access to prevention methods.
Trial design
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1) was a completed study with no specified phase, enrolling 9375 participants with HIV/AIDS. The study aimed to test innovative interventions designed to increase the uptake and use of biomedical HIV prevention options. This was achieved by engaging women and men at drinking venues in rural Kenya and Uganda. The trial compared outcomes between "Intervention Clusters" and "Control Clusters" to assess the effectiveness of these approaches.
Key results
The trial measured biomedical HIV prevention uptake at several time points:
- At 4 weeks, the mean uptake in Intervention Clusters was 23.7% of participants, compared to 24.1% of participants in Control Clusters.
- At 8 weeks, the mean uptake in Intervention Clusters was 23.8% of participants, compared to 24.1% of participants in Control Clusters.
- At 12 weeks, the mean uptake in Intervention Clusters was 23.8% of participants, compared to 24.1% of participants in Control Clusters.
What this means
The results from the OPAL-East Africa- Aim 1 study indicate that the innovative interventions tested to increase biomedical HIV prevention uptake in drinking venues in rural Kenya and Uganda did not lead to a notable difference in uptake rates compared to the control clusters. With uptake consistently around 24% in both groups across 4, 8, and 12 weeks, these findings suggest that the specific outreach strategies employed in the intervention clusters did not significantly enhance the adoption of prevention methods beyond what was observed in the control settings. This information is important for refining public health strategies aimed at increasing HIV prevention uptake, highlighting the need for further research into more impactful interventions or different delivery mechanisms to reach these populations effectively.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT05862857, titled "The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1)", were posted on 2026-03-11 on clinicaltrials.gov.